Swedish Pharmaceuticals & Biotech Most Popular Stocks

Swedish Orphan Biovitrum

Market Cap: SEK 100.7b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Camurus

Market Cap: SEK 30.0b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

AddLife

Market Cap: SEK 22.5b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Vitrolife

Market Cap: SEK 21.0b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Bonesupport Holding

Market Cap: SEK 16.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BioArctic

Market Cap: SEK 16.1b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Biotage

Market Cap: SEK 11.4b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

MedCap

Market Cap: SEK 6.6b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Swedencare

Market Cap: SEK 6.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Flerie

Market Cap: SEK 3.5b

A venture capital firm specializing in early-stage investments.

Cereno Scientific

Market Cap: SEK 2.9b

A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases worldwide.

BICO Group

Market Cap: SEK 2.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

BioInvent International

Market Cap: SEK 2.3b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Vicore Pharma Holding

Market Cap: SEK 1.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.7b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Genovis AB (publ.)

Market Cap: SEK 1.7b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Hansa Biopharma

Market Cap: SEK 1.6b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Egetis Therapeutics

Market Cap: SEK 1.2b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Diamyd Medical

Market Cap: SEK 1.2b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Xspray Pharma

Market Cap: SEK 1.2b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Dicot Pharma

Market Cap: SEK 1.1b

Engages in the development of pharmaceutical products in Sweden.

Saniona

Market Cap: SEK 1.1b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Infant Bacterial Therapeutics

Market Cap: SEK 777.3m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

Hamlet BioPharma

Market Cap: SEK 728.5m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Enzymatica

Market Cap: SEK 728.2m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

Cinclus Pharma Holding

Market Cap: SEK 703.7m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

SynAct Pharma

Market Cap: SEK 685.1m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

FluoGuide

Market Cap: SEK 569.3m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Magle Chemoswed Holding

Market Cap: SEK 562.1m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

Orexo

Market Cap: SEK 501.0m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Ascelia Pharma

Market Cap: SEK 479.2m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Moberg Pharma

Market Cap: SEK 437.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Active Biotech

Market Cap: SEK 415.2m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

IRLAB Therapeutics

Market Cap: SEK 382.3m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

Oncopeptides

Market Cap: SEK 374.3m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.